Individualization of irinotecan treatment: a review of pharmacokinetics, pharmacodynamics, and pharmacogenetics

FM de Man, AKL Goey, RHN van Schaik… - Clinical …, 2018 - Springer
Since its clinical introduction in 1998, the topoisomerase I inhibitor irinotecan has been
widely used in the treatment of solid tumors, including colorectal, pancreatic, and lung …

Organism-wide, cell-type-specific secretome mapping of exercise training in mice

W Wei, NM Riley, X Lyu, X Shen, J Guo, SH Raun… - Cell Metabolism, 2023 - cell.com
There is a significant interest in identifying blood-borne factors that mediate tissue crosstalk
and function as molecular effectors of physical activity. Although past studies have focused …

Double-network-structured graphene oxide-containing nanogels as photothermal agents for the treatment of colorectal cancer

C Fiorica, N Mauro, G Pitarresi, C Scialabba… - …, 2017 - ACS Publications
Here, we reported the production of hyaluronic acid/polyaspartamide-based double-network
nanogels for the potential treatment of colorectal carcinoma. Graphene oxide, thanks to the …

Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1

M de With, L van Doorn, E Kloet, A van Veggel… - Clinical …, 2023 - Springer
Background and objective Side effects of irinotecan treatment can be dose limiting and may
impair quality of life. In this study, we investigated the correlation between single nucleotide …

Expression of Topoisomerase 1 and carboxylesterase 2 correlates with irinotecan treatment response in metastatic colorectal cancer

C Shaojun, H Li, H Haixin, L Guisheng - Cancer biology & therapy, 2018 - Taylor & Francis
ABSTRACT Topoisomerase 1 (TOPO-1) and carboxylesterase 2 (CES-2) are found to play
crucial roles in the pathogenesis of various cancers. The prognostic role of TOPO-1 and …

PLX038A, a long-acting SN-38, penetrates the blood-tumor-brain-barrier, accumulates and releases SN-38 in brain tumors to increase survival of tumor bearing mice

J Jung, EL Schneider, W Zhang, H Song, M Zhang… - Scientific Reports, 2024 - nature.com
Central nervous system tumors have resisted effective chemotherapy because most
therapeutics do not penetrate the blood-tumor-brain-barrier. Nanomedicines between~ 10 …

Per-and polyfluoroalkyl substances exert strong inhibition towards human carboxylesterases

YZ Liu, LH Pan, Y Bai, K Yang, PP Dong… - Environmental Pollution, 2020 - Elsevier
PFASs are highly persistent in both natural and living environment, and pose a significant
risk for wildlife and human beings. The present study was carried out to determine the …

Dehydroepiandrosterone (DHEA) sensitizes irinotecan to suppress head and neck cancer stem-like cells by downregulation of WNT signaling

LJ Li, CH Li, PMH Chang, TC Lai, CY Yong… - Frontiers in …, 2022 - frontiersin.org
Purpose Current treatment options for head and neck squamous cell carcinoma (HNSCC)
are limited, especially for cases with cancer stem cell-induced chemoresistance and …

Comparative metabolism of DDAO benzoate in liver microsomes from various species

HY Ma, JD Yang, J Hou, LW Zou, Q Jin, DC Hao… - Toxicology in Vitro, 2017 - Elsevier
Abstract DDAB (6, 8-dichloro-9, 9-dimethyl-7-oxo-7, 9-dihydroacridin-2-yl benzoate) is a
newly developed near-infrared fluorescent probe for human carboxylesterase 2 (hCE2) …

Heterogenous chemosensitivity of a panel of organoid lines derived from small cell neuroendocrine carcinoma of the uterine cervix

M Tanaka, J Kondo, K Kaneko, H Endo, K Onuma… - Human Cell, 2021 - Springer
Small cell neuroendocrine carcinoma (SCNEC) of the uterine cervix is a rare disease with a
poor prognosis. The lack of established disease models has hampered therapy …